This Is Why with Dr. Busti

Dr. Busti will explain gallbladder anatomy and gallbladder physiology, connecting bile flow and gallstones to the clinical findings healthcare professionals encounter in practice.

Follow bile from hepatic production through gallbladder storage, concentration, and meal-triggered release. Learn how cholecystokinin coordinates delivery, how the cystic duct connects the gallbladder to the common bile duct, and why stone location changes the clinical consequences.

Apply this framework to cholelithiasis, cholecystitis, choledocholithiasis, cholangitis, and gallstone pancreatitis. The lecture connects structure and function to bedside findings and explains why stones alone do not establish acute gallbladder inflammation.

Compare the questions answered by gallbladder ultrasound, MRCP, and a HIDA scan, including the limitations of interpreting gallbladder ejection fraction. You will also learn why bile production continues after cholecystectomy. Anatomical illustrations, ultrasound examples, and a rotating 3D MRCP reconstruction help connect the concepts to clinical interpretation.

When we understand the why, we improve the how.

👉 Get more with a free membership at https://www.thisiswhy.health/
Access free downloads from our videos
Access deep-dive content from Dr. Busti
Organize content via playlists & collections
Join live Q&A
Receive member newsletters
Coupons & discounts for exam prep resources

Chapter Table of Contents
00:00 - Introduction
03:30 - Bile Production & the Biliary System
07:30 - Gallbladder Anatomy & Structure
12:00 - How the Gallbladder Stores & Concentrates Bile
16:30 - Bile Release, CCK, & the Sphincter of Oddi
21:00 - Gallstones & Biliary Obstruction
26:00 - Gallbladder Disorders & Clinical Symptoms
31:00 - Ultrasound, HIDA Scan, MRCP, & ERCP
35:48 - Why You Can Live Without a Gallbladder
37:29 - Six Key Takeaways & Clinical Applications

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#Gallbladder #GallbladderAnatomy #GallbladderPhysiology #Gallstones #DrBusti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines aligned with the principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Forest plots are an important tool in evidence-based medicine, yet many clinicians can recognize one without confidently interpreting what it is actually showing. In this episode of This Is Why with Dr. Busti, you'll learn how to read a forest plot, understand what each component represents, and evaluate what a meta-analysis is telling you about the evidence. 

You'll also learn how confidence intervals, pooled estimates, heterogeneity, study weighting, and sensitivity analyses influence interpretation of the evidence so you can become a more confident consumer of medical literature.

Topics Covered:
- How to read a forest plot
- Line of no effect
- Odds ratios, risk ratios, and confidence intervals
- Pooled estimates and the summary diamond
- Heterogeneity, I², and Cochran's Q
- Study weighting and precision
- Sensitivity analysis
- Critical appraisal of meta-analysis
- Applying forest plots to clinical decisions

If you found this episode helpful, subscribe for more evidence-based clinical education from This Is Why with Dr. Busti, where we explain the why so you can master the how.

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

Chapter Table of Contents
00:00 - Introduction
01:51 - Where Forest Plots Fit in Evidence-Based Medicine
03:19 - Cochrane and the History of Forest Plots
06:58 - How to Read a Forest Plot: Effect Measure, Model & Direction
09:53 - The Line of No Effect & Statistical Significance
11:36 -  Study Weights, Blobs & Confidence Intervals
16:10 - The Pooled Estimate & Overall Summary Effect
18:14 - Heterogeneity: Cochran’s Q, I² & Tau²
22:38 - Clinical Integration, Sensitivity Analysis, & Publication Bias
27:49 - Core Concepts

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#ForestPlot #MetaAnalysis #SystematicReview #EvidenceBasedMedicine #DrBusti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Systematic reviews and meta-analyses are often considered among the highest levels of clinical evidence—but only when they are performed using rigorous, transparent methods. In this episode of This Is Why with Dr. Busti, you'll learn the essential steps involved in conducting and critically evaluating a systematic review and meta-analysis, from developing a focused clinical question through assessing risk of bias, heterogeneity, and pooled results. 

Whether you're conducting research or interpreting published medical literature, understanding the systematic review process can help you evaluate the validity of its conclusions. Dr. Busti explains why each step matters and how understanding the methodology supports evidence-based clinical decision making.

Topics Covered:
- Systematic review and meta-analysis methodology
- PICO and PICOTS frameworks
- Inclusion and exclusion criteria
- Comprehensive literature search strategies
- Risk of bias assessment
- Cochrane Reviews
- Evidence synthesis and pooled estimates
- Fixed-effect vs random-effects models
- Heterogeneity, Cochran's Q, and I²
- Critical appraisal of medical literature

If you found this episode valuable, subscribe for more evidence-based clinical education from This Is Why with Dr. Busti, where we explain the why so you can master the how.

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/how-to-do-systematic-review-meta-analysis-ebm-key-steps

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

Chapter Table of Contents
00:00 - Introduction
04:22 - Key Steps in a Systematic Review & Meta-Analysis
08:31 - Defining the Question, Eligibility Criteria & Search Strategy
12:20 - Assessing Study Quality & Risk of Bias
16:29 - How Meta-Analysis Data Are Combined
24:38 - Effect Measures & Fixed vs. Random-Effects Models
31:12 - Choosing the Statistical Method: M-H, Peto & Inverse Variance
35:28 - Forest Plots, Pooled Estimates & Heterogeneity
42:48 - Core Concepts

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#SystematicReview #MetaAnalysis #CriticalAppraisal #EvidenceBasedMedicine #DrBusti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Systematic Review vs Meta-Analysis is one of the most commonly misunderstood topics in evidence-based medicine. In this episode of This Is Why, Dr. Busti explains the important differences between review articles, systematic reviews, and meta-analyses, why these terms should not be used interchangeably, and how each contributes to clinical decision-making. #SystematicReview #MetaAnalysis #EvidenceBasedMedicine

You'll learn why systematic reviews provide a reproducible, evidence-based synthesis of the literature while meta-analyses statistically combine results to estimate an overall treatment effect. Dr. Busti also discusses Cochrane Reviews, publication bias, heterogeneity, the strengths and limitations of evidence synthesis, and a classic cardiovascular example showing how pooled evidence can reveal a treatment signal before a single large trial settles the question.

Whether you're a student, resident, pharmacist, physician, nurse practitioner, physician assistant, or practicing clinician, understanding how to interpret systematic reviews and meta-analyses is an essential evidence-based medicine skill.

In this episode you'll learn:
- What distinguishes a review article from a systematic review
- Why systematic reviews follow reproducible methodologies
- How meta-analyses produce pooled estimates of treatment effect
- Why Cochrane Reviews are widely regarded as among the most rigorous evidence syntheses
- Common sources of bias in evidence synthesis
- Advantages and limitations of meta-analysis
- How systematic reviews and meta-analyses can influence clinical practice

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

Chapter Table of Contents
00:00 - Introduction
01:15 - Module Overview and Learning Objectives  
02:52 - What Is a Systematic Review?  
04:59 - What Is a Meta-Analysis?  
06:52 - Systematic Review vs. Traditional Review Article  
09:19 - Systematic Reviews, Meta-Analyses, & Cochrane Reviews  
14:24 - Benefits and Limitations of Meta-Analysis  
18:58 - Can Meta-Analysis Change Clinical Practice?
20:41 - Core Concepts

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#SystematicReview #MetaAnalysis #EvidenceBasedMedicine #CriticalAppraisal #DrBusti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Dr. Busti explains why the PARADIGM-HF trial changed treatment for heart failure with reduced ejection fraction (HFrEF), connecting sacubitril/valsartan to the clinical evidence behind angiotensin receptor-neprilysin inhibitor (ARNI) therapy.

Why replace an ACE inhibitor in a patient who seems stable? Follow the rationale for neprilysin inhibition, the role of natriuretic peptides, and the reason sacubitril is paired with valsartan. Then examine the comparison with enalapril: cardiovascular death or first heart-failure hospitalization, relative versus absolute benefit, symptomatic hypotension, and the run-in period that shaped trial eligibility.

This Landmark Clinical Trials episode also puts PIONEER-HF, PROVE-HF, PARAGON-HF, and PARADISE-MI into perspective without treating biomarker changes or remodeling associations as proof of a survival mechanism. The discussion connects AHA/ACC/HFSA guidance to practical heart failure treatment, including ARNI within the four foundational drug classes, switching precautions, dosing and monitoring, and interpretation of BNP versus NT-proBNP.

Designed for healthcare learners and practicing clinicians across medicine, nursing, and pharmacy, this lecture explains what the trial established, why the treatment strategy made sense, and where its findings should not be generalized.

When we understand the why, we improve the how.

👉 Get more with a free membership at https://www.thisiswhy.health/

Access free downloads from our videos

Access deep-dive content from Dr. Busti

Organize content via playlists & collections

Join live Q&A

Receive member newsletters

Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#PARADIGMHF #SacubitrilValsartan #HFrEF #ARNI #DrBusti

Speaker:

Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.

Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:

This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines aligned with the principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Trimethoprim-sulfamethoxazole, or TMP-SMX, and spironolactone can impair renal potassium excretion through different mechanisms. This lecture explains how trimethoprim’s amiloride-like inhibition of ENaC converges with mineralocorticoid-receptor antagonism—and why that can increase the risk of clinically important hyperkalemia.

Dr. Busti will explain how normal distal-nephron potassium handling works, which patients are most vulnerable, how to interpret the observational safety signal, and how clinicians can approach indication review, renal dosing, laboratory monitoring, medication reconciliation, and patient counseling.

Evidence discussed:

- Antoniou T, et al. BMJ. 2011;343:d5228. https://pubmed.ncbi.nlm.nih.gov/21911446/

- Antoniou T, et al. CMAJ. 2015;187(4):E138-E143. https://pubmed.ncbi.nlm.nih.gov/25646289/

- Spironolactone prescribing information: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4239da9e-dd0c-9af0-e063-6394a90a3cbb

- Sulfamethoxazole/trimethoprim prescribing information: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b89b5502-ce87-45a6-a43c-9891da3cfca4

When we understand the why, we improve the how.

👉 Get more with a free membership at https://www.thisiswhy.health/

Access free downloads from our videos

Access deep-dive content from Dr. Busti

Organize content via playlists & collections

Join live Q&A

Receive member newsletters

Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#DrugInteractions #Hyperkalemia #Spironolactone #TMPSMX #DrBusti

Speaker:

Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.

Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:

This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines aligned with the principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

The amiodarone and digoxin drug interaction is one of the most clinically important cardiovascular drug interactions to understand because it can raise digoxin exposure and increase the risk of digoxin toxicity.

In this episode of This Is Why, Dr. Busti explains why amiodarone can increase digoxin concentrations, how P-glycoprotein inhibition changes digoxin handling, and why clinicians should anticipate the need for digoxin dose adjustment and monitoring rather than react after symptoms appear.

You’ll learn why this interaction is not just a memorized warning, but a predictable pharmacokinetic and pharmacodynamic issue involving drug transport, renal elimination, cardiac conduction, and patient-specific monitoring.

Topics Covered:

Why digoxin has a narrow therapeutic window
How P-glycoprotein affects digoxin absorption and elimination
Why amiodarone increases digoxin exposure
Clinical signs of digoxin toxicity
Why nausea, fatigue, confusion, and bradycardia matter
How to think through dose reduction and monitoring
Why renal function and serum concentrations matter
Additive electrophysiologic effects on heart rate and conduction
How understanding the mechanism improves patient care

When we understand the why, we improve the how.

👉 Get more with a free membership at https://www.thisiswhy.health/

Access free downloads from our videos
Access deep-dive content from Dr. Busti
Organize content via playlists & collections
Join live Q&A
Receive member newsletters
Coupons & discounts for exam prep resources

Chapter Table of Contents
00:00 - Introduction
01:49 - Digoxin's Narrow Therapeutic Index
02:31 - P-Glycoprotein: The Key Transporter
04:53 - How Amiodarone Inhibits P-Glycoprotein
06:37 - Clinical Signs of Digoxin Toxicity
08:27 - Managing the Interaction
09:59 - Pharmacodynamic Effects on Cardiac Conduction
11:19 - Key Clinical Takeaways

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#Amiodarone #Digoxin #DrugInteraction #DigoxinToxicity #PGlycoprotein

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Likelihood ratios (LR) are one of the most clinically useful tools in diagnostic testing because they help clinicians determine whether a test meaningfully changes the probability of disease. In this episode of This Is Why with Dr. Busti, Dr. Anthony Busti explains how likelihood ratios integrate sensitivity, specificity, prevalence, and post-test probability into real-world clinical decision-making.

This Is Why understanding likelihood ratios (LR) matters for every clinician ordering diagnostic tests. Dr. Busti walks through how positive and negative likelihood ratios influence patient workups, when additional testing is warranted, and how clinicians determine whether a diagnostic test is truly useful.

Using practical examples including appendicitis evaluation with the speed bump sign, this episode demonstrates how likelihood ratios help guide evidence-based medicine (EBM) and shared clinical decision-making.

Topics Covered:
- Likelihood ratios (LR) explained
- Positive vs negative likelihood ratios
- Pre-test and post-test probability
- Disease prevalence and diagnostic testing
- Diagnostic decision-making principles
- Sensitivity and specificity integration
- Fagan nomogram basics
- Choosing useful diagnostic tests

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#LikelihoodRatios #DiagnosticTesting #EBM #PostTestProbability #DrBusti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Positive and negative predictive values are critical for understanding what diagnostic test results actually mean in clinical practice. In this episode of This Is Why with Dr. Busti, Dr. Busti explains how predictive values help clinicians determine the probability that a patient truly has — or does not have — a disease after diagnostic testing.

This Is Why understanding predictive values matters far beyond memorizing formulas. Dr. Busti breaks down how prevalence changes diagnostic interpretation, why false positives and false negatives matter clinically, and how positive and negative predictive values directly impact patient care decisions.

Using practical examples including pregnancy testing, appendicitis evaluation, and abdominal pain over speed bumps, this episode demonstrates how clinicians apply predictive values in real-world diagnostic reasoning.

Topics Covered:
- Positive predictive value explained
- Negative predictive value explained
- False positives vs false negatives
- Disease prevalence and diagnostic testing
- Pre-test probability basics
- Clinical interpretation of predictive values
- Diagnostic reasoning in practice
- Sensitivity vs specificity integration
- Appendicitis speed bump sign example
- Applying predictive values clinically

The goal = make medical education easy and clinically relevant.

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#PositivePredictiveValue #NegativePredictiveValue #DiagnosticTesting #EvidenceBasedMedicine #DrBusti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

ROC curves and the AUC (or c-statistic) are some of the most important — and most misunderstood — concepts in diagnostic testing and evidence-based medicine (EBM). In this episode of This Is Why with Dr. Busti, Dr. Busti explains how ROC curves help clinicians determine diagnostic test cutoffs, balance sensitivity and specificity, and improve diagnostic accuracy in real clinical practice.

This Is Why understanding ROC curves matters for clinicians interpreting laboratory tests, screening tools, and diagnostic assays. Dr. Busti breaks down area under the curve (AUC), false positives, false negatives, and why changing diagnostic thresholds directly impacts patient care decisions.

Using practical examples like diabetes diagnostic cutoffs and D-dimer testing, this episode explains how clinicians choose acceptable tradeoffs between sensitivity and specificity while minimizing diagnostic error.

Topics Covered:
- Receiver Operating Characteristic (ROC) curves explained
- Area under the curve (AUC)
- Sensitivity vs specificity tradeoffs
- Diagnostic test cutoff values
- Diagnostic accuracy principles
- Clinical interpretation of ROC curves
- Applying ROC curves in practice

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resourcex

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

#ROCCurves #DiagnosticTesting #SensitivityAndSpecificity #EvidenceBasedMedicine #DrBusti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.